Predictions
Exact Sciences
Start price
Target price
Perf. (%)
€55.41
11.11.23
11.11.23
€105.00
11.12.23
11.12.23
7.56%
25.11.23
25.11.23
Revenue growth >5% per year expected
Rising EBIT margin expected
Standard Investments for future growth
negative Cash Flow expected
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.86
04.11.23
04.11.23
€89.00
04.12.23
04.12.23
-4.82%
05.12.23
05.12.23
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.86
04.11.23
04.11.23
€89.00
04.12.23
04.12.23
-4.82%
05.12.23
05.12.23
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.86
04.11.23
04.11.23
€89.00
04.12.23
04.12.23
-4.82%
05.12.23
05.12.23
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Sarepta Therapeutics
Start price
Target price
Perf. (%)
€114.20
29.10.23
29.10.23
€150.00
31.03.26
31.03.26
-
30.10.23
30.10.23
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€568.50
11.10.23
11.10.23
€558.00
11.10.24
11.10.24
-7.48%
14.12.23
14.12.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€33.12
11.10.23
11.10.23
-
11.10.24
11.10.24
14.79%
12.12.23
12.12.23
Known brand
Could be worthwhile Investment >10% per year
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€38.99
04.10.23
04.10.23
€22.00
04.10.24
04.10.24
-16.75%
14.10.23
14.10.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€533.50
19.09.23
19.09.23
€558.00
19.09.24
19.09.24
6.56%
11.10.23
11.10.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market